1. Home
  2. HNI vs ARQT Comparison

HNI vs ARQT Comparison

Compare HNI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNI
  • ARQT
  • Stock Information
  • Founded
  • HNI 1944
  • ARQT 2016
  • Country
  • HNI United States
  • ARQT United States
  • Employees
  • HNI N/A
  • ARQT N/A
  • Industry
  • HNI Office Equipment/Supplies/Services
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • HNI Consumer Discretionary
  • ARQT Health Care
  • Exchange
  • HNI Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • HNI 2.1B
  • ARQT 2.1B
  • IPO Year
  • HNI N/A
  • ARQT 2020
  • Fundamental
  • Price
  • HNI $40.21
  • ARQT $24.76
  • Analyst Decision
  • HNI Strong Buy
  • ARQT Strong Buy
  • Analyst Count
  • HNI 1
  • ARQT 7
  • Target Price
  • HNI $70.00
  • ARQT $22.17
  • AVG Volume (30 Days)
  • HNI 515.6K
  • ARQT 2.5M
  • Earning Date
  • HNI 10-28-2025
  • ARQT 10-28-2025
  • Dividend Yield
  • HNI 3.38%
  • ARQT N/A
  • EPS Growth
  • HNI 16.22
  • ARQT N/A
  • EPS
  • HNI 2.98
  • ARQT N/A
  • Revenue
  • HNI $2,593,100,000.00
  • ARQT $317,929,000.00
  • Revenue This Year
  • HNI $5.80
  • ARQT $73.37
  • Revenue Next Year
  • HNI $3.78
  • ARQT $31.36
  • P/E Ratio
  • HNI $13.49
  • ARQT N/A
  • Revenue Growth
  • HNI 1.15
  • ARQT 129.21
  • 52 Week Low
  • HNI $39.66
  • ARQT $8.29
  • 52 Week High
  • HNI $58.42
  • ARQT $27.08
  • Technical
  • Relative Strength Index (RSI)
  • HNI 26.53
  • ARQT 68.34
  • Support Level
  • HNI $44.23
  • ARQT $19.60
  • Resistance Level
  • HNI $46.46
  • ARQT $27.08
  • Average True Range (ATR)
  • HNI 1.14
  • ARQT 1.32
  • MACD
  • HNI -0.44
  • ARQT 0.38
  • Stochastic Oscillator
  • HNI 8.01
  • ARQT 68.92

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: